Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

aeglea biotherapeutics

POPULAR ARTICLES

Aeglea BioTherapeutics Doses First Patient in Phase 3 Trial of Pegzilarginase in Arginase 1 Deficiency

NASDAQ:ADAP

Biotech Trends 2018: Immuno-oncology Disappoints

Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency

LATEST ARTICLES

NASDAQ:AGLE

Pharmaceutical Investing

Aeglea BioTherapeutics Announces Positive Clinical Update

Aeglea BioTherapeutics Announces Positive Interim Clinical Data and Completion of Enrollment for Ongoing Phase 1/2 Trial of Pegzilarginase

Latest News

Westport Announces Annual General and Special Meeting and Timing of Q1 2025 Financial Results

Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties

Canadian Investment Regulatory Organization Trade Resumption - FYL

Finlay Minerals Enters into Earn-In Agreements with Freeport for its PIL & ATTY Properties

Forte Minerals Engages Trion Communications GmbH for European Investor Awareness